Probiotec Shareholders Vote in Favor of Acquisition by Pyridam via Scheme of Arrangement
Probiotec (ASX:PBP) shareholders voted in favor of a scheme of arrangement acquisition by Pyridam, according to a Wednesday Australian bourse filing. The scheme remains subject to court approval at a
Probiotec to Request Federal Court Approve Scheme Meeting After Meeting
Probiotec (ASX:PBP) will request the Federal Court of Australia approve a scheme of arrangement for Pyridam to acquire it if shareholders vote to approve at a May 29 meeting, according to a Tuesday Au
Foreign Investment Review Board Clears Probiotec Acquisition by Pyridam Farma
Australia's Foreign Investment Review Board has cleared Pyridam Farma's (IDX:PYFA) scheme of arrangement acquisition proposal for Probiotec (ASX:PBP) with the receipt of a "no objection letter" from t
Probiotec (ASX:PBP) Shareholders Have Earned a 15% CAGR Over the Last Five Years
AU Morning Wrap: ASX Shares Drop; Energy Producers Rise
Stocks to watch: Iress, EML Payments, Pilbara.
Probiotec Enters Scheme Implementation Bid With Indonesia-Listed Pyridam Farma
Probiotec (ASX:PBP) entered into a scheme implementation deed with Indonesia-listed Pyridam Farma (IDX:PYFA), under which shareholders will receive AU$3.00 per share. The scheme consideration implies
Probiotec Limited's (ASX:PBP) CEO Compensation Is Looking A Bit Stretched At The Moment
Probiotec Limited's (ASX:PBP) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
While Insiders Own 31% of Probiotec Limited (ASX:PBP), Retail Investors Are Its Largest Shareholders With 41% Ownership
AU Morning Wrap: ASX Flat; AMA Group Plunges 45% After $55m Raise
Stocks to watch: AMA Group, Fortescue Metals, Treasury Wine Estate.
Probiotec Target Price Raised 1.5% to A$3.35/Share by Morgans>PBP.AU
Probiotec Target Price Raised 1.5% to A$3.35/Share by Morgans>PBP.AU
Is Now The Time To Put Probiotec (ASX:PBP) On Your Watchlist?
Probiotec Limited's (ASX:PBP) Stock Is Going Strong: Is the Market Following Fundamentals?
Is Probiotec Limited's (ASX:PBP) Stock's Recent Performance A Reflection Of Its Financial Health?
No Data